Metrics, INC. Pharmaceutical development & analytical services/robert murphy/analytical testing of satraplatin, 2 lots. (1)
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201300116P
- Awardee
-
Mayne Pharma Commercial LLC UEI EJMTUZC46YN3 Part of Mayne Pharma Group LIMITED
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,661
Award facts
- Contract value 100% obligated
- $6,660.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Greenville, NC, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | -$0 | |
| Original award | $6,661 |
About this award
The National Cancer Institute awarded a purchase order to Mayne Pharma Commercial LLC valued at $6,660.53 on March 1, 2013, for analytical testing of satraplatin across two lots. Performance occurs in Greenville, North Carolina under a firm fixed-price arrangement. The order completed January 25, 2018.
Quick answers
Who was awarded contract HHSN261201300116P?
HHSN261201300116P was awarded to Mayne Pharma Commercial LLC by National Cancer Institute (National Institutes of Health) on March 1, 2013.
How much is contract HHSN261201300116P worth?
The government has obligated $6,661 on HHSN261201300116P.
Was contract HHSN261201300116P competed?
The extent of competition for HHSN261201300116P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award